Literature DB >> 10188995

Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha.

D A Hall1, I J Beresford, C Browning, H Giles.   

Abstract

The effect of interleukin-8 (IL-8) and growth-related oncogene alpha (GROalpha) on [35S]-guanosine 5'-O-(3-thiotriphosphate) ([35S]GTPgammaS) binding, forskolin-stimulated cyclic AMP accumulation and cytosolic calcium concentration were determined in recombinant CHO cells expressing HA-tagged CXC-chemokine receptors 1 and 2 (CXCR1 and CXCR2). Radioligand binding assays confirmed that the binding profiles of the recombinant receptors were similar to those of the native proteins. IL-8 displaced [125I]-IL-8 binding to CXCR1 and CXCR2 with pKi values of 8.89+/-0.05 and 9.27+/-0.03, respectively. GROalpha, a selective CXCR2 ligand, had a pKi value of 9.66+/-0.39 at CXCR2 but a pKi>8 at CXCR1. Calcium mobilization experiments were also consistent with previous reports on native receptors. Activation of both receptors resulted in stimulation of [35S]GTPgammaS binding and inhibition of adenylyl cyclase. A comparison of the functional data at CXCRI showed that a similar potency order (IL-8> >GROalpha) was obtained in all three assays. However, at CXCR2 whilst the potency orders for calcium mobilization and inhibition of adenylyl cyclase were similar (IL-8 > or = GROalpha), the order was reversed for stimulation of [35S]GTPgammaS binding (GROalpha > IL-8). All of the functional responses at both receptors were inhibited by pertussis toxin (PTX), suggesting coupling to a Gi/Go protein. However, the calcium mobilization induced by IL-8 at CXCR1 was not fully inhibited by PTX, suggesting an interaction with a G-protein of the Gq family. Our results with pertussis toxin also suggested that, in the [35S]GTPgammaS binding assay, CXCR1 displays some constitutive activity. Thus, we have characterized the binding and several functional responses at HA-tagged CXCRs 1 and 2 and have shown that their pharmacology agrees well with that of the native receptors. We also have preliminary evidence that CXCR1 displays constitutive activity in our cell line and that CXCR2 may traffic between different PTX sensitive G-proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188995      PMCID: PMC1565838          DOI: 10.1038/sj.bjp.0702329

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  Regulation of effectors by G-protein alpha- and beta gamma-subunits. Recent insights from studies of the phospholipase c-beta isoenzymes.

Authors:  A J Morris; S Scarlata
Journal:  Biochem Pharmacol       Date:  1997-08-15       Impact factor: 5.858

Review 2.  Cloning and characterization of human chemokine receptors.

Authors:  C A Power; T N Wells
Journal:  Trends Pharmacol Sci       Date:  1996-06       Impact factor: 14.819

3.  Agonist action at D2(short) dopamine receptors determined in ligand binding and functional assays.

Authors:  B R Gardner; D A Hall; P G Strange
Journal:  J Neurochem       Date:  1997-12       Impact factor: 5.372

4.  IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors.

Authors:  M E Hammond; G R Lapointe; P H Feucht; S Hilt; C A Gallegos; C A Gordon; M A Giedlin; G Mullenbach; P Tekamp-Olson
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

Review 5.  Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1995-07       Impact factor: 14.819

6.  CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.

Authors:  S K Ahuja; J C Lee; P M Murphy
Journal:  J Biol Chem       Date:  1996-01-05       Impact factor: 5.157

7.  TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines.

Authors:  F Petersen; A Ludwig; H D Flad; E Brandt
Journal:  J Immunol       Date:  1996-03-01       Impact factor: 5.422

8.  Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8.

Authors:  P Proost; C De Wolf-Peeters; R Conings; G Opdenakker; A Billiau; J Van Damme
Journal:  J Immunol       Date:  1993-02-01       Impact factor: 5.422

9.  Chemokine binding and activities mediated by the mouse IL-8 receptor.

Authors:  J Lee; G Cacalano; T Camerato; K Toy; M W Moore; W I Wood
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

10.  Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophil-activating protein. NH2-terminal amino acid sequence identity with melanoma growth stimulatory activity.

Authors:  J M Schröder; N L Persoon; E Christophers
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

View more
  21 in total

1.  Pharmacological characterization of the chemokine receptor, CCR5.

Authors:  Anja Mueller; Nasir G Mahmoud; Marc C Goedecke; Jane A McKeating; Philip G Strange
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 2.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 3.  [Oral anticholinergics in overactive bladder].

Authors:  H Madersbacher
Journal:  Urologe A       Date:  2006-07       Impact factor: 0.639

Review 4.  Regulation of heterotrimeric G protein signaling in airway smooth muscle.

Authors:  Raymond B Penn; Jeffrey L Benovic
Journal:  Proc Am Thorac Soc       Date:  2008-01-01

5.  NF-κB-dependent IL-8 induction by prostaglandin E(2) receptors EP(1) and EP(4).

Authors:  F Neuschäfer-Rube; A Pathe-Neuschäfer-Rube; S Hippenstiel; M Kracht; G P Püschel
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

7.  Regulation of Staphylococcus aureus-induced CXCR1 expression via inhibition of receptor mobilization and receptor shedding during dual receptor (TNFR1 and IL-1R) neutralization.

Authors:  Puja Dutta; Sahin Sultana; Rajen Dey; Biswadev Bishayi
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

8.  A novel phenylcyclohex-1-enecarbothioamide derivative inhibits CXCL8-mediated chemotaxis through selective regulation of CXCR2-mediated signalling.

Authors:  Helen Ha; Tim Bensman; Henry Ho; Paul M Beringer; Nouri Neamati
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

9.  The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization.

Authors:  C Taylor Gilliland; Catherina L Salanga; Tetsuya Kawamura; JoAnn Trejo; Tracy M Handel
Journal:  J Biol Chem       Date:  2013-09-20       Impact factor: 5.157

10.  Alpha-defensin 1 (human neutrophil protein 1) as an antichemotactic agent for human polymorphonuclear leukocytes.

Authors:  P S Grutkoski; C T Graeber; Y P Lim; A Ayala; H H Simms
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.